FX1   Click here for help

GtoPdb Ligand ID: 9672

Compound class: Synthetic organic
Comment: FX1 is a potent and selective BCL6 inhibitor rationally designed to target BCL6-driven diffuse large B cell lymphoma [1]. FX1 inhibits binding of BCL6 corepressor proteins and formation of functional repression complexes at its endogenous target genes (BCL6 target genes include CD69, CXCR4, and CDKN1A loci).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 144.1
Molecular weight 369.98
XLogP -0.21
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)CCN1C(=S)SC(=C2C(=O)NC3C2C=C(Cl)C=C3)C1=O
Isomeric SMILES OC(=O)CCN1C(=S)S/C(=C/2\C(=O)NC3C2C=C(Cl)C=C3)/C1=O
InChI InChI=1S/C14H11ClN2O4S2/c15-6-1-2-8-7(5-6)10(12(20)16-8)11-13(21)17(14(22)23-11)4-3-9(18)19/h1-2,5,7-8H,3-4H2,(H,16,20)(H,18,19)/b11-10-
InChI Key NLLDCQPHRJHMSX-KHPPLWFESA-N
Bioactivity Comments
FX1 is active in repressing diffuse large B cell lymphomas in vitro and in vivo [1].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
BCL6 transcription repressor Primary target of this compound Hs Inhibitor Binding 5.2 pKd - 1
pKd 5.2 (Kd 7x10-6 M) [1]
Description: Binding of compound to BCL6 BTB domain using microscale thermophoresis.